作者: Andreas Skolarikos , Gerasimos Alivizatos , Pilar Laguna , Jean de la Rosette
DOI: 10.1016/J.EURURO.2006.12.031
关键词:
摘要: Abstract Objectives To provide a comprehensive review of the evidence supporting necessity for follow-up after nephrectomy renal cell carcinoma. Methods We searched Medline, MeSH, EMBASE, and Cochrane databases using terms "renal cancer," "kidney neoplasm," "follow-up," "surveillance," "prognosis," "staging" to look human/English language/Randomized Controlled Trials/Clinical trials/Review articles/Meta-analysis/Practiced Guidelines, Editorials. Results No consensus currently exists on surveillance guidelines radical or partial The rationale strategies is detect local recurrence metastatic disease allow appropriate treatment. Most protocols recommend various all tumour stages. emphasis should be during first 3–5 yr nephrectomy. There no about which investigations performed at what intervals. surgeons rely symptom enquiry, physical examination, chest x-ray, computed tomography scanning. A protocol based stage initial adapted by majority investigators. Patients followed similarly basis stage-oriented protocols. combination prognostic factors requires further validation over stage-based paucity in literature regarding patients with hereditary forms Conclusions Current are observational case studies. While this fact precludes high level evidence-based guidelines, we have conclude that best available date.